mWTX-330, an IL 12 INDUKINE Molecule, Activates and Reshapes Tumor-infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity

Overview of attention for article published in Cancer Immunology Research, April 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#5 of 1,570)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 47 news outlets

twitter: 14 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 11 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 19 X posts from 14 X users, with an upper bound of 59,335 followers.

RT @CIR_AACR: An IL12 prodrug that’s selectively activated in the TME and generates potent antitumor immunity is identified. Read about its…

06 Aug 2023

Reply Repost Favourite

RT @CIR_AACR: An IL12 prodrug that’s selectively activated in the TME and generates potent antitumor immunity is identified. Read about its…

03 Aug 2023

Reply Repost Favourite

RT @CIR_AACR: An IL12 prodrug that’s selectively activated in the TME and generates potent antitumor immunity is identified. Read about its…

03 Aug 2023

Reply Repost Favourite

An IL12 prodrug that’s selectively activated in the TME and generates potent antitumor immunity is identified. Read about its effects on the metabolic health of TILs and associated toxicity vs. systemic IL12. Study by Nirschl & Salmeron. https://t.co/K

02 Aug 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 15 additional X posts.